Scientists dive deep into RSV vaccine immune response
NCT ID NCT07185399
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study looks at how the immune system of adults aged 60 and older responds to an approved RSV vaccine. Researchers will measure antibodies and track side effects for 6 months after vaccination. The goal is to learn more about how the vaccine protects people and find early signs of a strong immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.